New anti-HIV-1 therapies and combinations: current data and prospects

Mpox Vaccine Hesitancy Among Sexually Active People with HIV in Care at Risk for mpox.

AIDS and behavior·2026

Racial Inequity in Prescription of Semaglutide Among Eligible People With HIV.

Diabetes care·2025

Progressive natural killer cell dysfunction in advanced-stage clear-cell renal cell carcinoma and association with clinical outcomes.

ESMO open·2025

Correlates of Intimate Partner Violence, Including Psychological Partner Violence, in a Multisite U.S. Cohort of People in HIV Care.

AIDS and behavior·2024

Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the US.

medRxiv : the preprint server for health sciences·2021

Anemia risk factors among people living with HIV across the United States in the current treatment era: a clinical cohort study.

BMC infectious diseases·2020

Long-term effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV and resistance-associated mutations.

AIDS (London, England)·2026

Comparing carbon emissions from oral tenofovir disoproxil fumarate/emtricitabine for preexposure prophylaxis and long-acting injectables for HIV prevention.

AIDS (London, England)·2026

The additive value of coronary calcium in identifying cardiovascular risk in ageing people with HIV.

AIDS (London, England)·2026

Same-day initiation of tenofovir alafenamide-based pre-exposure prophylaxis with drug-level feedback for transgender women in Uganda.

AIDS (London, England)·2026

Viral suppression in models of care for improving engagement of antiretroviral therapy in postpartum women living with HIV.

AIDS (London, England)·2026

Clusters and outbreaks contribute disproportionately to future HIV transmission in the United States.

AIDS (London, England)·2026

Inhibition of miR-301a-3p Expression Promotes Ferroptosis: A New Target for Ferroptosis Treatment in TNBC.

The breast journal·2026

Research progress on BTG2 in non‑tumor diseases (Review).

International journal of molecular medicine·2026

Advances in sirtuin research in lung diseases (Review).

International journal of molecular medicine·2026

Breaking the cycle of fibrosis: Ferroptosis as a therapeutic target (Review).

International journal of molecular medicine·2026

[Expression of Concern] Inhibition of TMEM45A suppresses proliferation, induces cell cycle arrest and reduces cell invasion in human ovarian cancer cells.

Oncology reports·2026

Do Generic EGFR-TKIs Perform as Well as Innovators? Real-World Evidence from Gefitinib-Treated EGFR-Mutated NSCLC in Indonesia.

Asian Pacific journal of cancer prevention : APJCP·2026

Related Experiment Videos

New anti-HIV-1 therapies and combinations: current data and prospects

Related Concept Videos

Mpox Vaccine Hesitancy Among Sexually Active People with HIV in Care at Risk for mpox.

Racial Inequity in Prescription of Semaglutide Among Eligible People With HIV.

Progressive natural killer cell dysfunction in advanced-stage clear-cell renal cell carcinoma and association with clinical outcomes.

Correlates of Intimate Partner Violence, Including Psychological Partner Violence, in a Multisite U.S. Cohort of People in HIV Care.

Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the US.

Anemia risk factors among people living with HIV across the United States in the current treatment era: a clinical cohort study.

Long-term effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV and resistance-associated mutations.

Comparing carbon emissions from oral tenofovir disoproxil fumarate/emtricitabine for preexposure prophylaxis and long-acting injectables for HIV prevention.

The additive value of coronary calcium in identifying cardiovascular risk in ageing people with HIV.

Same-day initiation of tenofovir alafenamide-based pre-exposure prophylaxis with drug-level feedback for transgender women in Uganda.

Viral suppression in models of care for improving engagement of antiretroviral therapy in postpartum women living with HIV.

Clusters and outbreaks contribute disproportionately to future HIV transmission in the United States.

Inhibition of miR-301a-3p Expression Promotes Ferroptosis: A New Target for Ferroptosis Treatment in TNBC.

Research progress on BTG2 in non‑tumor diseases (Review).

Advances in sirtuin research in lung diseases (Review).

Breaking the cycle of fibrosis: Ferroptosis as a therapeutic target (Review).

[Expression of Concern] Inhibition of TMEM45A suppresses proliferation, induces cell cycle arrest and reduces cell invasion in human ovarian cancer cells.

Do Generic EGFR-TKIs Perform as Well as Innovators? Real-World Evidence from Gefitinib-Treated EGFR-Mutated NSCLC in Indonesia.

Related Experiment Videos

New anti-HIV-1 therapies and combinations: current data and prospects

Related Concept Videos

Related Articles